These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 26170008

  • 1. Factors associated with frovatriptan response in patients with migraine: A prospective, observational study.
    Seo JG, Park SP.
    Cephalalgia; 2016 Apr; 36(5):493-8. PubMed ID: 26170008
    [Abstract] [Full Text] [Related]

  • 2. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
    Göbel H, Heinze A.
    Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
    [Abstract] [Full Text] [Related]

  • 3. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M.
    CNS Drugs; 2012 Sep 01; 26(9):791-811. PubMed ID: 22900951
    [Abstract] [Full Text] [Related]

  • 4. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.
    Newman LC, Harper S, Jones BA, Campbell J.
    J Womens Health (Larchmt); 2009 Aug 01; 18(8):1265-73. PubMed ID: 19627225
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
    Savi L, Mogavero S, Egan CG.
    Drug Des Devel Ther; 2014 Aug 01; 8():983-92. PubMed ID: 25092964
    [Abstract] [Full Text] [Related]

  • 6. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M, Ravasio R.
    Clin Drug Investig; 2009 Aug 01; 29(11):693-702. PubMed ID: 19813772
    [Abstract] [Full Text] [Related]

  • 7. Frovatriptan review.
    Markus F, Mikko K.
    Expert Opin Pharmacother; 2007 Dec 01; 8(17):3029-33. PubMed ID: 18001261
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic evaluation of frovatriptan.
    Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P.
    Expert Opin Drug Metab Toxicol; 2011 Nov 01; 7(11):1449-58. PubMed ID: 21929465
    [Abstract] [Full Text] [Related]

  • 9. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.
    Headache; 2012 May 01; 52(5):749-64. PubMed ID: 22188311
    [Abstract] [Full Text] [Related]

  • 10. Frovatriptan in the practice of office-based neurologists/pain therapists: Results of postmarketing surveillance study ALADIN.
    Wallasch TM.
    Adv Ther; 2010 Jan 01; 27(1):56-62. PubMed ID: 20140543
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.
    Tullo V, Bussone G, Omboni S, Barbanti P, Cortelli P, Curone M, Peccarisi C, Benedetto C, Pezzola D, Zava D, Allais G.
    Neurol Sci; 2013 May 01; 34 Suppl 1():S87-91. PubMed ID: 23695053
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R, Géraud G, Goldstein J, Cady R, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [Abstract] [Full Text] [Related]

  • 13. Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study.
    Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Fierro B, Brighina F.
    J Headache Pain; 2012 Jul 01; 13(5):401-6. PubMed ID: 22592864
    [Abstract] [Full Text] [Related]

  • 14. Frovatriptan as preemptive treatment for fasting-induced migraine.
    Latsko M, Silberstein S, Rosen N.
    Headache; 2011 Mar 01; 51(3):369-374. PubMed ID: 21269298
    [Abstract] [Full Text] [Related]

  • 15. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G, Rolando S, De Lorenzo C, Benedetto C.
    Expert Rev Neurother; 2014 Aug 01; 14(8):867-77. PubMed ID: 25056381
    [Abstract] [Full Text] [Related]

  • 16. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A, Ryan R, Goldstein J, Keywood C.
    Headache; 2002 Apr 01; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [Abstract] [Full Text] [Related]

  • 17. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.
    Elkind AH, MacGregor EA.
    Expert Rev Neurother; 2008 May 01; 8(5):723-36. PubMed ID: 18457529
    [Abstract] [Full Text] [Related]

  • 18. Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.
    Allais G, Benedetto C.
    Drug Des Devel Ther; 2016 May 01; 10():3225-3236. PubMed ID: 27757013
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

  • 20. Extended cycle combined oral contraceptives and prophylactic frovatriptan during the hormone-free interval in women with menstrual-related migraines.
    Coffee AL, Sulak PJ, Hill AJ, Hansen DJ, Kuehl TJ, Clark JW.
    J Womens Health (Larchmt); 2014 Apr 27; 23(4):310-7. PubMed ID: 24450487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.